REPORTING OF CLINICAL TRIAL RESULTS TO PATIENTS AND PUBLIC When considering preparation of information that is for patients and their carers/families. It is important to take into account the language used and to allow opportunity to tailor information depending on the patients’ experience/current situation: - Refer to Guidance on use of Plain Language and Readability checks in the PICD toolki t here At the End of the Trial At the end of the trial summary results in lay language will be provided on the CRUK website at the following link: A trial of a vaccine called AST -VAC2 in non small cell lung cancer . Additionally, a link to the CRUK lay summary of the results will be a dded to the HRA website . CRUK CDD will provide Investigator Sites with a .pdf copy of the results from the CRUK trials database for distribution to pa tients and their families (as appropriate and at the discretion of the investigator). 9.